Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.03
THC's Cash to Debt is ranked lower than
91% of the 237 Companies
in the Global Medical Care industry.

( Industry Median: 0.36 vs. THC: 0.03 )
Ranked among companies with meaningful Cash to Debt only.
THC' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.04 Max: 0.29
Current: 0.03
0
0.29
Equity to Asset 0.03
THC's Equity to Asset is ranked lower than
92% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 0.46 vs. THC: 0.03 )
Ranked among companies with meaningful Equity to Asset only.
THC' s Equity to Asset Range Over the Past 10 Years
Min: 0.01  Med: 0.17 Max: 0.41
Current: 0.03
0.01
0.41
Interest Coverage 1.16
THC's Interest Coverage is ranked lower than
91% of the 189 Companies
in the Global Medical Care industry.

( Industry Median: 6.08 vs. THC: 1.16 )
Ranked among companies with meaningful Interest Coverage only.
THC' s Interest Coverage Range Over the Past 10 Years
Min: 0.66  Med: 1.23 Max: 1.82
Current: 1.16
0.66
1.82
F-Score: 5
Z-Score: 0.97
WACC vs ROIC
4.99%
3.73%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 5.67
THC's Operating margin (%) is ranked lower than
61% of the 233 Companies
in the Global Medical Care industry.

( Industry Median: 7.96 vs. THC: 5.67 )
Ranked among companies with meaningful Operating margin (%) only.
THC' s Operating margin (%) Range Over the Past 10 Years
Min: -8.66  Med: 5.82 Max: 8.21
Current: 5.67
-8.66
8.21
Net-margin (%) -0.75
THC's Net-margin (%) is ranked lower than
78% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 5.01 vs. THC: -0.75 )
Ranked among companies with meaningful Net-margin (%) only.
THC' s Net-margin (%) Range Over the Past 10 Years
Min: -9.5  Med: 0.18 Max: 13.5
Current: -0.75
-9.5
13.5
ROE (%) -18.49
THC's ROE (%) is ranked lower than
93% of the 215 Companies
in the Global Medical Care industry.

( Industry Median: 9.22 vs. THC: -18.49 )
Ranked among companies with meaningful ROE (%) only.
THC' s ROE (%) Range Over the Past 10 Years
Min: -124.98  Med: 2.68 Max: 92.79
Current: -18.49
-124.98
92.79
ROA (%) -0.66
THC's ROA (%) is ranked lower than
78% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 3.95 vs. THC: -0.66 )
Ranked among companies with meaningful ROA (%) only.
THC' s ROA (%) Range Over the Past 10 Years
Min: -8.75  Med: 0.19 Max: 13.89
Current: -0.66
-8.75
13.89
ROC (Joel Greenblatt) (%) 11.94
THC's ROC (Joel Greenblatt) (%) is ranked lower than
64% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 18.85 vs. THC: 11.94 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
THC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -14.52  Med: 11.28 Max: 15.25
Current: 11.94
-14.52
15.25
Revenue Growth (3Y)(%) 30.90
THC's Revenue Growth (3Y)(%) is ranked higher than
95% of the 172 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. THC: 30.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
THC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -13.7  Med: -0.20 Max: 32.4
Current: 30.9
-13.7
32.4
EBITDA Growth (3Y)(%) 20.10
THC's EBITDA Growth (3Y)(%) is ranked higher than
74% of the 141 Companies
in the Global Medical Care industry.

( Industry Median: 8.30 vs. THC: 20.10 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
THC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -47.1  Med: 7.70 Max: 31.5
Current: 20.1
-47.1
31.5
» THC's 10-Y Financials

Financials (Next Earnings Date: 2016-05-02)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

THC Guru Trades in Q1 2015

Richard Perry 1,580,000 sh (New)
Paul Singer 1,022,000 sh (New)
Vanguard Health Care Fund 2,053,200 sh (+40.63%)
Louis Moore Bacon 27,424 sh (+24.66%)
Mario Gabelli 15,050 sh (+0.33%)
Larry Robbins 13,812,831 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
Paul Tudor Jones 7,185 sh (-19.30%)
» More
Q2 2015

THC Guru Trades in Q2 2015

Jim Simons 37,775 sh (New)
Joel Greenblatt 20,284 sh (New)
Steven Cohen 4,000 sh (New)
Louis Moore Bacon 170,176 sh (+520.54%)
Paul Tudor Jones 19,326 sh (+168.98%)
Larry Robbins 14,792,313 sh (+7.09%)
Mario Gabelli 15,050 sh (unchged)
Paul Singer Sold Out
Richard Perry Sold Out
Vanguard Health Care Fund 1,399,100 sh (-31.86%)
» More
Q3 2015

THC Guru Trades in Q3 2015

Ray Dalio 10,647 sh (New)
Steven Cohen 462,600 sh (+11465.00%)
Jim Simons 197,675 sh (+423.30%)
Larry Robbins 16,490,230 sh (+11.48%)
Louis Moore Bacon Sold Out
Vanguard Health Care Fund Sold Out
Joel Greenblatt Sold Out
Mario Gabelli 15,040 sh (-0.07%)
Paul Tudor Jones 5,600 sh (-71.02%)
» More
Q4 2015

THC Guru Trades in Q4 2015

Louis Moore Bacon 40,156 sh (New)
Paul Tudor Jones 13,400 sh (+139.29%)
Larry Robbins 17,890,230 sh (+8.49%)
Steven Cohen 150,000 sh (unchged)
Mario Gabelli 15,040 sh (unchged)
Jim Simons Sold Out
Steven Cohen Sold Out
Ray Dalio Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with THC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Tenet Healthcare Corp

Guru, Philanthropist Larry Robbins Adds to 3 Healthcare-Related Holdings Robbins increased his stake in insurance company Humana
Guru Larry Robbins (Trades, Portfolio), the founder and CEO of Glenview Capital Management, also serves on the Robin Hood Foundation Board of Directors, as well as the board for Teach for America. Read more...
Larry Robbins Raises Stake in Tenet Healthcare Guru's position goes up 11% with purchase of nearly 1.7 million shares
Larry Robbins (Trades, Portfolio), founder, portfolio manager and CEO of hedge fund Glenview Capital Management, raised his stake in Tenet Healthcare Corp. (NYSE:THC) Wednesday by more than 11% with the purchase of 1,697,917 shares for an average price of $36.30 per share. The purchase had a 0.24% impact on Robbins’ portfolio. Read more...

Ratios

vs
industry
vs
history
Forward P/E 13.79
THC's Forward P/E is ranked higher than
73% of the 75 Companies
in the Global Medical Care industry.

( Industry Median: 16.81 vs. THC: 13.79 )
Ranked among companies with meaningful Forward P/E only.
N/A
P/B 4.49
THC's P/B is ranked lower than
78% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 2.52 vs. THC: 4.49 )
Ranked among companies with meaningful P/B only.
THC' s P/B Range Over the Past 10 Years
Min: 1.37  Med: 5.14 Max: 100.25
Current: 4.49
1.37
100.25
P/S 0.17
THC's P/S is ranked higher than
96% of the 230 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. THC: 0.17 )
Ranked among companies with meaningful P/S only.
THC' s P/S Range Over the Past 10 Years
Min: 0.05  Med: 0.33 Max: 0.72
Current: 0.17
0.05
0.72
PFCF 4.26
THC's PFCF is ranked higher than
95% of the 112 Companies
in the Global Medical Care industry.

( Industry Median: 20.31 vs. THC: 4.26 )
Ranked among companies with meaningful PFCF only.
THC' s PFCF Range Over the Past 10 Years
Min: 3.11  Med: 82.33 Max: 514.15
Current: 4.26
3.11
514.15
POCF 3.04
THC's POCF is ranked higher than
93% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 14.87 vs. THC: 3.04 )
Ranked among companies with meaningful POCF only.
THC' s POCF Range Over the Past 10 Years
Min: 1.31  Med: 6.82 Max: 15.63
Current: 3.04
1.31
15.63
EV-to-EBIT 16.60
THC's EV-to-EBIT is ranked higher than
58% of the 178 Companies
in the Global Medical Care industry.

( Industry Median: 19.43 vs. THC: 16.60 )
Ranked among companies with meaningful EV-to-EBIT only.
THC' s EV-to-EBIT Range Over the Past 10 Years
Min: -274.4  Med: 13.60 Max: 1356.9
Current: 16.6
-274.4
1356.9
EV-to-EBITDA 9.45
THC's EV-to-EBITDA is ranked higher than
75% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 13.63 vs. THC: 9.45 )
Ranked among companies with meaningful EV-to-EBITDA only.
THC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -34  Med: 8.00 Max: 22.7
Current: 9.45
-34
22.7
Shiller P/E 303.32
THC's Shiller P/E is ranked lower than
95% of the 44 Companies
in the Global Medical Care industry.

( Industry Median: 31.64 vs. THC: 303.32 )
Ranked among companies with meaningful Shiller P/E only.
THC' s Shiller P/E Range Over the Past 10 Years
Min: 230.8  Med: 276.00 Max: 332.1
Current: 303.32
230.8
332.1
Current Ratio 1.20
THC's Current Ratio is ranked lower than
57% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 1.35 vs. THC: 1.20 )
Ranked among companies with meaningful Current Ratio only.
THC' s Current Ratio Range Over the Past 10 Years
Min: 1.11  Med: 1.39 Max: 1.96
Current: 1.2
1.11
1.96
Quick Ratio 1.13
THC's Quick Ratio is ranked lower than
55% of the 223 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. THC: 1.13 )
Ranked among companies with meaningful Quick Ratio only.
THC' s Quick Ratio Range Over the Past 10 Years
Min: 1.03  Med: 1.31 Max: 1.85
Current: 1.13
1.03
1.85
Days Inventory 8.47
THC's Days Inventory is ranked higher than
73% of the 165 Companies
in the Global Medical Care industry.

( Industry Median: 16.80 vs. THC: 8.47 )
Ranked among companies with meaningful Days Inventory only.
THC' s Days Inventory Range Over the Past 10 Years
Min: 8.92  Med: 10.47 Max: 13.35
Current: 8.47
8.92
13.35
Days Sales Outstanding 52.95
THC's Days Sales Outstanding is ranked lower than
66% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 43.55 vs. THC: 52.95 )
Ranked among companies with meaningful Days Sales Outstanding only.
THC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.89  Med: 53.87 Max: 62.54
Current: 52.95
46.89
62.54
Days Payable 42.07
THC's Days Payable is ranked lower than
52% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 43.92 vs. THC: 42.07 )
Ranked among companies with meaningful Days Payable only.
THC' s Days Payable Range Over the Past 10 Years
Min: 40.4  Med: 48.85 Max: 56.74
Current: 42.07
40.4
56.74

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.76
THC's Price/Projected FCF is ranked lower than
51% of the 87 Companies
in the Global Medical Care industry.

( Industry Median: 1.76 vs. THC: 1.76 )
Ranked among companies with meaningful Price/Projected FCF only.
THC' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.67  Med: 1.65 Max: 4.06
Current: 1.76
0.67
4.06
Price/Median PS Value 0.52
THC's Price/Median PS Value is ranked higher than
94% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 1.06 vs. THC: 0.52 )
Ranked among companies with meaningful Price/Median PS Value only.
THC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.19  Med: 1.28 Max: 5.44
Current: 0.52
0.19
5.44
Price/Graham Number 0.63
THC's Price/Graham Number is ranked higher than
87% of the 136 Companies
in the Global Medical Care industry.

( Industry Median: 2.24 vs. THC: 0.63 )
Ranked among companies with meaningful Price/Graham Number only.
THC' s Price/Graham Number Range Over the Past 10 Years
Min: 0.59  Med: 3.16 Max: 9.73
Current: 0.63
0.59
9.73
Earnings Yield (Greenblatt) (%) 6.05
THC's Earnings Yield (Greenblatt) (%) is ranked higher than
66% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. THC: 6.05 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
THC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.1  Med: 6.20 Max: 15.7
Current: 6.05
0.1
15.7
Forward Rate of Return (Yacktman) (%) 27.60
THC's Forward Rate of Return (Yacktman) (%) is ranked higher than
90% of the 102 Companies
in the Global Medical Care industry.

( Industry Median: 11.10 vs. THC: 27.60 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
THC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -103.1  Med: 0.50 Max: 28.9
Current: 27.6
-103.1
28.9

More Statistics

Revenue(Mil) $18638
EPS $ -1.41
Beta0.86
Short Percentage of Float13.38%
52-Week Range $21.39 - 60.93
Shares Outstanding(Mil)98.53

Analyst Estimate

Dec16 Dec17 Dec18
Revenue(Mil) 18,935 19,755 20,391
EPS($) 1.85 2.34 3.26
EPS without NRI($) 1.85 2.34 3.26

Business Description

Industry: Health Care Providers » Medical Care
Compare:NYSE:MD, ASX:SHL, FRA:CLS1, NAS:ACHC, NAS:WOOF, SZSE:300015 » details
Traded in other countries:THC1.Germany,
Tenet Healthcare Corp, a Nevada corporation was incorporated in 1975. It is an investor-owned company whose subsidiaries and affiliates operate regionally focused, integrated health care delivery networks with a significant presence in several large urban and suburban markets. At the core of its networks are acute care and specialty hospitals that, together with its strategically aligned outpatient facilities and related businesses, allow them to provide a comprehensive range of health care services in the communities they serve. The Company primarily operated 77 hospitals, 183 outpatient centers, six health plans, six accountable care networks and Conifer Health Solutions, LLC ("Conifer"), which provides business process solutions to more than 700 hospital and other clients nationwide. It provides comprehensive operational management for revenue cycle functions, including patient access, health information management, revenue integrity and patient financial services. They also offer communications and engagement solutions to optimize the relationship between providers and patients. In addition, its management services offerings have expanded to support value-based performance through clinical integration, financial risk management and population health management. For financial reporting purposes, its business lines are classified into two separate reportable business segments - hospital operations and other, and Conifer. Its subsidiaries operated 77 hospitals, including four academic medical centers, two children's hospitals, three specialty hospitals and a critical access hospital, with a total of 20,293 licensed beds, serving primarily urban and suburban communities in 14 states. Of those hospitals, 72 were owned by its subsidiaries, and five were owned by third parties and leased by its subsidiaries. They are also in the process of constructing the new Resolute Health Hospital and Wellness Campus in New Braunfels, Texas, which is expected to be completed in or around May 2014. In addition, its subsidiaries operated a long-term acute care hospital and owned or leased and operated a number of medical office buildings, all of which were located on, or nearby, its hospital campuses. Furthermore, its subsidiaries operated 183 free-standing and provider-based outpatient centers in 16 states including diagnostic imaging centers, ambulatory surgery centers, urgent care centers and satellite emergency departments, among others. They also owned over 500 physician practices. Many of its hospitals also offer a wide range of clinical research studies, giving patients access to innovative care. The Company also own or control six accountable care networks - in Florida, California, Illinois, Michigan and Texas - and participate in two additional accountable care networks through collaborations with other health care providers in its markets in Arizona and Massachusetts. These networks operate using a range of payment and delivery models th
» More Articles for THC

Headlines

Articles On GuruFocus.com
Guru, Philanthropist Larry Robbins Adds to 3 Healthcare-Related Holdings Dec 06 2015 
Insiders Buy Stock in Wynn Resorts, Bank of New York Mellon Oct 25 2015 
Larry Robbins Raises Stake in Tenet Healthcare Oct 05 2015 
Obamacare Makes HCA a Buy Aug 24 2015 
Insider Buys Round-up: Tenet Healthcare and Sprint Corp Aug 14 2015 
Distressed Debt Investor Paul Singer Buys Citrix Systems Jun 11 2015 
Humana And Concentra To Part Ways Mar 27 2015 
Tenet Healthcare And United Surgical JV For $1.93 Billion Mar 24 2015 
Mario Gabelli’s Equity Income Fund Q3 2014 Commentary Oct 29 2014 
Time to Buy Tenet Healthcare? Aug 22 2014 

More From Other Websites
Should You Buy Tenet Healthcare (THC) Ahead of Earnings? Apr 29 2016
Universal Health's Solid Acute Care Numbers Could Bode Well for its Peers Apr 28 2016
Tipp Hill Cashes Out of Gold Stocks, Puts It Into Healthcare Apr 26 2016
Tenet Appoints Tim Adams as CEO of Texas Region Apr 25 2016
Verity Health System hires COO after Daughters of Charity deal Apr 21 2016
Tenet Healthcare Hires Robert Webb As SVP And Chief Human Resources Officer Apr 21 2016
Tenet Appoints Robert W. K. Webb Chief Human Resources Officer Apr 21 2016
Tenet Appoints Robert W. K. Webb Chief Human Resources Officer Apr 21 2016
7 Stocks, 7 trades: CMG, HOG, THC & more Apr 13 2016
Morning Gap Apr 13 2016
Tenet Healthcare upgraded by Susquehanna Apr 13 2016
Tenet to Join S&P MidCap 400 After Losing Place in S&P 500 Apr 08 2016
ULTA Makes it to the S&P 500 on Solid Underlying Growth Apr 08 2016
Ulta Salon, Cosmetics & Fragrance Set to Join the S&P 500; Tenet Healthcare to Join S&P MidCap 400 Apr 07 2016
Tenet Appoints Howard Hacker Chief Compliance Officer Apr 07 2016
Tenet Appoints Howard Hacker Chief Compliance Officer Apr 07 2016
Tenet to Report First Quarter Results on May 2 Apr 06 2016
Tenet to Report First Quarter Results on May 2 Apr 06 2016
Tenet Healthcare Divests Atlanta-Area Hospitals to WellStar (revised) Apr 05 2016
Brookwood Baptist Health launches new brand Apr 05 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK